Kostas Stamatopoulos, MD, PhD, is a specialist in Hematology, Director of the Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hellas, Thessaloniki, Greece. He also holds the positions of Visiting Professor at the Karolinska Institute, Stockholm, Sweden; and, Research Collaborator of the Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Dr Stamatopoulos is the coordinator of the Greek Precision Medicine Network in Oncology; Board member of ERIC, the European Research Initiative on CLL; founding member of the IMGT CLL-DB initiative and the IgCLL group, both operating under the auspices of ERIC; Board member of the Splenic Lymphoma Group; member of the Steering Group of the Euroclonality-NGS Consortium. Dr Stamatopoulos is a member of the Hellenic Society of Haematology, the European Haematology Association, the American Society of Hematology, amongst others, and has served in different committees of these organizations. His research interests include: precision medicine in cancer; immunobiology of lymphoid malignancies; and, patient empowerment in care.